z-logo
open-access-imgOpen Access
Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009–2015
Author(s) -
Sadia Shakoor,
Sabira Tahseen,
Kauser Jabeen,
Razia Fatima,
Faisal Malik,
Alamdar Hussain Rizvi,
Rumina Hasan
Publication year - 2016
Publication title -
international journal of mycobacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 20
eISSN - 2212-554X
pISSN - 2212-5531
DOI - 10.1016/j.ijmyco.2016.07.008
Subject(s) - mycobacterium tuberculosis , tuberculosis , drug resistance , haemophilus influenzae , antibiotic resistance , population , shigella , medicine , multiple drug resistance , antibiotics , microbiology and biotechnology , biology , environmental health , bacteria , genetics , pathology , salmonella
Fluoroquinolones (FQs) are important anti-tuberculous drugs for the treatment of multidrug-resistant (MDR) tuberculosis. Resistance to FQs leads to fewer options for treatment of tuberculosis (TB), and infection with such strains may also require longer treatment duration. Trends of resistance in Mycobacterium tuberculosis (MTB) are indicators of MTB-resistance evolution. Drivers of such resistance need to be understood and studied to inform preventive strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom